124 related articles for article (PubMed ID: 28960148)
21. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
22. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
23. Protection against thrombosis in mice lacking PAR3.
Weiss EJ; Hamilton JR; Lease KE; Coughlin SR
Blood; 2002 Nov; 100(9):3240-4. PubMed ID: 12384423
[TBL] [Abstract][Full Text] [Related]
24. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
25. Regulation of plasmin-induced protease-activated receptor 4 activation in platelets.
Mao Y; Jin J; Daniel JL; Kunapuli SP
Platelets; 2009 May; 20(3):191-8. PubMed ID: 19437337
[TBL] [Abstract][Full Text] [Related]
26. The role of PAR4 in thrombin-induced thromboxane production in human platelets.
Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Teng CM
Thromb Haemost; 2003 Aug; 90(2):299-308. PubMed ID: 12888878
[TBL] [Abstract][Full Text] [Related]
27. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
[TBL] [Abstract][Full Text] [Related]
28. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
30. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
31. Differential anti-thrombotic benefit and bleeding risk profiles of antagonists of protease-activated receptor 1 and 4 in Cynomolgus Macaques.
Wickham LA; Sitko G; Stranieri-Michener M; Handt L; Basso A; Fried S; Chu L; Maderia M; Owens K; Castriota G; Chen Z; Metzger JM; Imbriglio J; Wang X; Cai TQ
Thromb Res; 2016 Sep; 145():133-9. PubMed ID: 27318768
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury.
Kolpakov MA; Rafiq K; Guo X; Hooshdaran B; Wang T; Vlasenko L; Bashkirova YV; Zhang X; Chen X; Iftikhar S; Libonati JR; Kunapuli SP; Sabri A
J Mol Cell Cardiol; 2016 Jan; 90():21-9. PubMed ID: 26643815
[TBL] [Abstract][Full Text] [Related]
33. A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets.
Sánchez Centellas D; Gudlur S; Vicente-Carrillo A; Ramström S; Lindahl TL
Thromb Res; 2017 Jun; 154():84-92. PubMed ID: 28448853
[TBL] [Abstract][Full Text] [Related]
34. Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race.
Edelstein LC; Simon LM; Lindsay CR; Kong X; Teruel-Montoya R; Tourdot BE; Chen ES; Ma L; Coughlin S; Nieman M; Holinstat M; Shaw CA; Bray PF
Blood; 2014 Nov; 124(23):3450-8. PubMed ID: 25293779
[TBL] [Abstract][Full Text] [Related]
35. Drupin, a thrombin-like protease prompts platelet activation and aggregation through protease-activated receptors.
Manjuprasanna VN; Urs AP; Rudresha GV; Milan Gowda MD; Jayachandra K; Hiremath V; Rajaiah R; Vishwanath BS
J Cell Biochem; 2021 Aug; 122(8):870-881. PubMed ID: 33748988
[TBL] [Abstract][Full Text] [Related]
36. PKCtheta is required for hemostasis and positive regulation of thrombin-induced platelet aggregation and alpha-granule secretion.
Cohen S; Braiman A; Shubinsky G; Ohayon A; Altman A; Isakov N
Biochem Biophys Res Commun; 2009 Jul; 385(1):22-7. PubMed ID: 19433059
[TBL] [Abstract][Full Text] [Related]
37. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
38. PAR3 is a cofactor for PAR4 activation by thrombin.
Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
[TBL] [Abstract][Full Text] [Related]
39. A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling.
Rodriguez BAT; Bhan A; Beswick A; Elwood PC; Niiranen TJ; Salomaa V; ; Trégouët DA; Morange PE; Civelek M; Ben-Shlomo Y; Schlaeger T; Chen MH; Johnson AD
Am J Hum Genet; 2020 Aug; 107(2):211-221. PubMed ID: 32649856
[TBL] [Abstract][Full Text] [Related]
40. The PAR4 Platelet Thrombin Receptor Variant rs773902 does not Impact the Incidence of Thrombotic or Bleeding Events in a Healthy Older Population.
Selvadurai MV; Riaz M; Xie S; Tonkin AM; McNeil JJ; Lacaze P; Hamilton JR
Thromb Haemost; 2022 Jul; 122(7):1130-1138. PubMed ID: 34852379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]